Medindia

X

Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda™

Friday, February 3, 2017 Medico Legal News J E 4
Advertisement
Will Also Report Second Quarter 2017 Results and Discuss Next Steps in its Development Programs

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Biotech Stocks Under Scanner -- Mast Therapeutics,...
S
Axovant Sciences Announces $55.0 Million Venture D...